| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Repligen Corporation |
| Information provided by: | Repligen Corporation |
| ClinicalTrials.gov Identifier: | NCT00036244 |
Purpose
The purpose of the study is to determine whether multiple doses of secretin are safe and effective in the treatment of children with autism.
| Condition | Intervention | Phase |
|
Autism |
Drug: RG1068 (Synthetic Human Secretin) |
Phase III |
| MedlinePlus related topics: | Autism |
| Drug Information available for: | Secretin Human secretin |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Efficacy Study |
| Official Title: | A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Assess the Efficacy, Safety and Tolerability of RG1068 (Synthetic Human Secretin) in Children With Autism |
Eligibility
| Ages Eligible for Study: | 32 Months to 59 Months |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Autism
Contacts and Locations| United States, Arizona | |||||
| Southwest Autism Research Center | |||||
| Phoenix, Arizona, United States | |||||
| United States, California | |||||
| UCLA Pediatric Neurology | |||||
| Los Angeles, California, United States, 90095-1752 | |||||
| Children's Hospital and Research Center at Oakland | |||||
| Oakland, California, United States, 94609 | |||||
| United States, Colorado | |||||
| 1st Allergy & Clinical Research Center | |||||
| Centennial, Colorado, United States, 80112 | |||||
| United States, Florida | |||||
| Miami Children's Hospital | |||||
| Miami, Florida, United States | |||||
| Alachua Family Psychiatry | |||||
| Gainesville, Florida, United States, 32607 | |||||
| United States, Indiana | |||||
| Riley Children's Hospital | |||||
| Indianapolis, Indiana, United States, 46202-5200 | |||||
| United States, Louisiana | |||||
| The Clinical Trials Center:A Division of Children's Hospital | |||||
| Metairie, Louisiana, United States, 70006 | |||||
| United States, Massachusetts | |||||
| Hardy Healthcare Associates | |||||
| Hingham, Massachusetts, United States | |||||
| United States, Michigan | |||||
| Children's Hospital of Michigan | |||||
| Detroit, Michigan, United States, 48201 | |||||
| United States, New Jersey | |||||
| University of Medicine and Dentistry of New Jersey | |||||
| Newark, New Jersey, United States, 07107 | |||||
| United States, New York | |||||
| Schneider Children's Hospital | |||||
| New Hyde Park, New York, United States | |||||
| United States, Ohio | |||||
| The Ohio State University | |||||
| Columbus, Ohio, United States, 43210 | |||||
| United States, Utah | |||||
| Children's Biomedical Center of Utah | |||||
| Sandy, Utah, United States, 84093 | |||||
| United States, Washington | |||||
| Puget Sound Neurology | |||||
| Edmonds, Washington, United States, 98026 | |||||
| Repligen Corporation |
More Information
Related Info
|
| Study ID Numbers: | RG1068-04 |
| First Received: | May 8, 2002 |
| Last Updated: | August 4, 2005 |
| ClinicalTrials.gov Identifier: | NCT00036244 |
| Health Authority: | United States: Food and Drug Administration |
|
|
|
|
|
